JHS Sven.Lab.
Q1 FY22 Earnings Call Analysis
Personal Products
fundraise: Nocapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
💰fundraise
Any current/future new fundraising through debt or equity?
- No current plans for fundraising through debt or equity.
- All organic and inorganic growth initiatives are planned to be funded through internal accruals and existing cash reserves.
- The company has sufficient cash reserves to support expansions.
- If any larger-scale funding needs arise in the future, the company will evaluate and decide on raising external funds at that time.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- Major capital expenditure focused on new product categories: talcum powder and ayurvedic formulations.
- Purchased land in Jammu & Kashmir for setting up a new manufacturing facility.
- New talc facility established at the existing campus; cream and lotion facility also under development on the same campus.
- Talc facility is operational as of May 2022, production scaling expected from Q2 FY23.
- Plans for further geographical expansion with manufacturing facilities in southern and central India; evaluating acquisition in the south.
- Pursuing inorganic growth through potential acquisitions; three companies in advanced discussions with due diligence ongoing, expected conclusion in a couple of months.
- Expansion initiatives to be funded primarily through internal accruals; debt issuance considered only if larger funding is required.
- Product portfolio expansion planned to include soap bars and personal care products like lotions and shampoos.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Focus on multi-pronged business growth including geographical expansion to Southern and Central India through M&A, brownfield, and greenfield projects.
- Addition of new product categories such as talcum powder, soap bars, and personal care products to expand portfolio.
- Increasing market share in export markets (US, Europe) with expected 10-12% revenue contribution going forward.
- Active participation in international trade shows to boost export growth opportunities.
- New talcum powder and ayurvedic facility commercialized from May 2022 expected to contribute positively.
- Adding new clients, with four new private label clients added recently.
- Expect gradual revenue growth as production upscales from Q2 FY23 onwards.
- Cash reserves to fund organic and inorganic growth initiatives.
- Overall strategy aims to return the company to a growth path after recent revenue decline due to third-party business drop.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- The company is focusing on multi-pronged growth through geographical expansion into Southern and Central India via M&A, brownfield, and greenfield projects.
- New product additions include talcum powder, soap bars, and personal care items, expected to enhance the product portfolio and client share.
- Talcum powder facility became operational in May 2022, with production scaling expected from Q2 FY23.
- Outlook for exports is positive, aiming for 10-12% of revenues from new markets like the US and Europe, driven by India's emerging role as an alternative to China.
- The company expects internal accrual funding for organic and inorganic growth initiatives, indicating controlled financial risk.
- Increasing marketing budget to support trade shows and promotions intended to boost domestic and export growth.
- Challenges include past negative EBITDA due to low capacity utilization, but new product launches and client additions are expected to improve profitability and EPS in the near future.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- The company is actively pursuing new clients and has added four new clients in the private label business during the current year.
- New product categories like talcum powder have started manufacturing as of May 2022, indicating fresh orders in the pipeline.
- The company aims to expand its product portfolio to include soap bars and personal care products, suggesting pending orders in these segments.
- Export market interest is positive, with expected growth to contribute 10-12% in revenues going forward, reflecting potential upcoming export orders.
- The company is engaged in ongoing discussions for inorganic growth (M&A), with three companies under consideration, which may translate into future orderbooks post-deal closure.
- Contract manufacturing is stable but depends on clients' brand performance, with some reduction noted due to a client's market share decline.
- Overall, new client additions and product launches indicate a growing orderbook, supported primarily by internal accrual-funded capacity expansions.
